Enterprise Value
-9.004M
Cash
25.14M
Avg Qtr Burn
-4.321M
Short % of Float
0.35%
Insider Ownership
6.82%
Institutional Own.
16.06%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ONA-XR Details Solid tumor/s, Cancer, Breast cancer, ER+/HER2- breast cancer, Metastatic breast cancer to brain | Failed Discontinued | |
ONA-XR Details Solid tumor/s, Cancer, Ovarian cancer, Endometrial cancer | Failed Discontinued | |
ONA-XR Details Solid tumor/s, Cancer, Breast cancer, ER+/HER2- breast cancer, Metastatic breast cancer to brain | Failed Discontinued |